Ultimovacs Balance Sheet Health
Financial Health criteria checks 5/6
Ultimovacs has a total shareholder equity of NOK217.5M and total debt of NOK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NOK252.8M and NOK35.4M respectively.
Key information
0%
Debt to equity ratio
NOK 0
Debt
| Interest coverage ratio | n/a |
| Cash | NOK 170.40m |
| Equity | NOK 217.46m |
| Total liabilities | NOK 35.35m |
| Total assets | NOK 252.82m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ULTIO's short term assets (NOK178.1M) exceed its short term liabilities (NOK22.7M).
Long Term Liabilities: ULTIO's short term assets (NOK178.1M) exceed its long term liabilities (NOK12.6M).
Debt to Equity History and Analysis
Debt Level: ULTIO is debt free.
Reducing Debt: ULTIO had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ULTIO has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: ULTIO has sufficient cash runway for 1.8 years if free cash flow continues to reduce at historical rates of 23.9% each year.